Fuchs Michaela Aa, Grabner Alexander, Shi Melody, Murray Susan L, Burke Emily J, Latic Nejla, Thiriveedi Venkataramana, Roper Jatin, Ide Shintaro, Abe Koki, Kitai Hiroki, Souma Tomokazu, Wolf Myles
Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Division of Nephrology, Department of Medicine and.
J Clin Invest. 2024 Dec 17;135(4):e179882. doi: 10.1172/JCI179882.
Vitamin D regulates mineral homeostasis. The most biologically active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), is synthesized by CYP27B1 from 25-dihydroxyvitamin D (25D) and is inactivated by CYP24A1. Human monogenic diseases and genome-wide association studies support a critical role for CYP24A1 in regulation of mineral homeostasis, but little is known about its tissue-specific effects. Here, we describe the responses of mice with inducible global deletion, kidney-specific, and intestine-specific deletion of Cyp24a1 to dietary calcium challenge and chronic kidney disease (CKD). Global and kidney-specific Cyp24a1 deletion caused similar syndromes of systemic vitamin D intoxication: elevated circulating 1,25D, 25D, and fibroblast growth factor 23 (FGF23), activation of vitamin D target genes in the kidney and intestine, hypercalcemia, and suppressed parathyroid hormone (PTH). In contrast, mice with intestine-specific Cyp24a1 deletion demonstrated activation of vitamin D target genes exclusively in the intestine, despite no changes in systemic vitamin D levels. In response to a high calcium diet, PTH was suppressed, despite normal serum calcium. In mice with CKD, intestinal Cyp24a1 deletion decreased PTH and FGF23 without precipitating hypercalcemia. These results implicate kidney CYP24A1 in systemic vitamin D regulation while independent local effects of intestinal CYP24A1 could be targeted to treat secondary hyperparathyroidism in CKD.
维生素D调节矿物质稳态。维生素D最具生物活性的形式,1,25 - 二羟基维生素D(1,25D),由CYP27B1从25 - 二羟基维生素D(25D)合成,并被CYP24A1灭活。人类单基因疾病和全基因组关联研究支持CYP24A1在矿物质稳态调节中起关键作用,但对其组织特异性作用知之甚少。在此,我们描述了可诱导的Cyp24a1全球缺失、肾脏特异性缺失和肠道特异性缺失的小鼠对饮食钙挑战和慢性肾脏病(CKD)的反应。全球和肾脏特异性Cyp24a1缺失导致类似的全身性维生素D中毒综合征:循环中的1,25D、25D和成纤维细胞生长因子23(FGF23)升高,肾脏和肠道中维生素D靶基因激活,高钙血症,以及甲状旁腺激素(PTH)受抑制。相比之下,肠道特异性Cyp24a1缺失的小鼠尽管全身维生素D水平无变化,但仅在肠道中显示维生素D靶基因激活。对高钙饮食的反应中,尽管血清钙正常,PTH仍受抑制。在患有CKD的小鼠中,肠道Cyp24a1缺失降低了PTH和FGF23,而未引发高钙血症。这些结果表明肾脏CYP24A1参与全身性维生素D调节,而肠道CYP24A1的独立局部作用可作为治疗CKD继发性甲状旁腺功能亢进的靶点。